Iovance Biotherapeutics (IOVA) Plunges 33% as CEO Resigns Day after BLA Delay
Iovance Biotherapeutics (NASDAQ: IOVA) halted ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
